Atlas Trials

The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated

Clinical trial NCT03131232 · UNKNOWN

Trial details

NCT number
NCT03131232
Sponsor
RWTH Aachen University
Status
UNKNOWN
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2015-12-10
Primary completion
2017-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.